OCEANSIDE, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB:ISCO) http://www.internationalstemcell.com, a California-based stem cell therapeutics company, today announced that its wholly-owned subsidiary Lifeline Cell Technology has entered into an agreement to manufacture adipose (fat)-derived stem cell research products for Cytori Therapeutics.
